SAGASIGN

Serial Number 79297241
Registration 6350878
700

Registration Progress

Application Filed
Mar 5, 2020
Under Examination
Approved for Publication
Mar 2, 2021
Published for Opposition
Mar 2, 2021
Registered
May 18, 2021

Trademark Image

SAGASIGN

Basic Information

Serial Number
79297241
Registration Number
6350878
Filing Date
March 5, 2020
Registration Date
May 18, 2021
Published for Opposition
March 2, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 18, 2021
Registration
Registered
Classes
005 042 044

Rights Holder

SAGA Diagnostics AB

99
Address
Medicon Village,
Scheelevägen 2 SE-223 81 Lund
SE

Ownership History

SAGA Diagnostics AB

Original Applicant
99
SE

SAGA Diagnostics AB

Owner at Publication
99
SE

SAGA Diagnostics AB

Original Registrant
99
SE

Legal Representation

Attorney
Sarah J. Schneider

USPTO Deadlines

Next Deadline
665 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-18)
Due Date
May 18, 2027
Grace Period Ends
November 18, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Jul 24, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Dec 15, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 15, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Dec 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 15, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 21, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Sep 25, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 3, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 3, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 18, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 18, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 15, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 24, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 24, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 10, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 22, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 31, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 30, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 30, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 20, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 3, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 3, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 19, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 19, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 19, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 19, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Nov 19, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 19, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 17, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 16, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 13, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 10, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 6, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 5, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; diagnostic preparations and materials, namely, medical diagnostic reagents; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; clinical medical reagents; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents for medical use; diagnostic testing materials for medical use; genetic identity tests comprised of reagents for medical purposes; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for analysis of blood and other liquids; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; reactants for medical diagnosis being diagnostic reagents for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for analytical purposes for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for blood grouping for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use in analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use in diagnostic pregnancy tests; veterinary diagnostic reagents
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Analysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research in the field of cancer and infectious diseases and medical research; clinical research in the field of cancer and infectious diseases; clinical trials for others; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to laboratory testing; consultancy relating to pharmaceutical research and development; medical laboratory services; medical research; medical research laboratory services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment; provision of information and data relating to medical and veterinary pharmaceutical and diagnostic research and development; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; services for assessing the efficiency of pharmaceuticals; services for assessing the efficiency of veterinary drugs
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Genetic counseling; genetic testing of animals for diagnostic or treatment purposes; laboratory analysis being medical analysis for diagnostic and treatment of persons provided by medical laboratories; medical and healthcare services; medical monitoring of patients; stem cell therapy services; medical services; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; blood bank services; bowel cancer screening services; breast cancer screening services; cervical cancer screening services; colonoscopy screening services; medical consultancy and information services relating to medical products; DNA screening for medical purposes; genetic testing for medical purposes; hepatitis screening services; lung cancer screening services; medical advice in the field of pregnancy; medical analysis for the diagnosis and treatment of persons relating to cancer and infectious diseases; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients relating to cancer and infectious diseases; medical analysis services relating to the treatment of persons for cancer and infectious diseases provided by a medical laboratory; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical and health services relating to DNA, genetics and genetic testing; medical care and analysis of cancer diagnosis relating to patient treatment; medical consultations; medical diagnostic services; medical evaluation services; medical analysis services for diagnostic and treatment purposes of blood samples taken from patients provided by medical laboratories; medical screening; medical services for the treatment of skin cancer; medical services in the field of oncology; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; prostate cancer screening services; providing cancer screening services; providing information in the field of medicine; RNA or DNA analysis for cancer diagnosis and prognosis; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for the preparation of medical reports relating to health care; technical consultancy services relating to medical health; testicular cancer screening services
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
SAGA SIGN

Classification

International Classes
005 042 044